Sino Biopharmaceutical(SBMFF)
$0.620.00 (0.00%)
SBMFF
Sino Biopharmaceutical stock forecast
$0.62
At close:0.00 (0.00%)
Sino Biopharmaceutical (SBMFF) Stock Forecast & Price Target
45 Followers
SBMFF Analyst Ratings
Strong Buy
11Buy0Hold0Sell
Based on 11 analysts giving stock ratings to Sino Biopharmaceutical in the past 3 months
SBMFF Stock 12 Month Forecast
Average Price Target
$1.12▲(81.85% Upside)Based on 11 Wall Street analysts offering 12 month price targets for Sino Biopharmaceutical in the last 3 months. The average price target is $1.12 with a high forecast of $1.38 and a low forecast of $0.89. The average price target represents a 81.85% change from the last price of $0.62.
Past 12 Months12 Month ForecastJan2026Oct2026
High$1.38
Average$1.12
Low$0.89
Highest Price TargetHighest$1.38Average Price Target$1.12Lowest Price TargetLowest$0.89
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | CICC | $1.14 | buy | 83.73%Upside | Reiterated | 11/05/26 | ||
| Unknown AnalystNot Ranked | Bank of China | $0.97 | buy | 56.89%Upside | Reiterated | 11/05/26 | ||
| Unknown AnalystNot Ranked | UBS | $0.98 | buy | 58.96%Upside | Reiterated | 10/28/26 | ||
| Unknown AnalystNot Ranked | Guosheng Securities | $1.05 | buy | 69.28%Upside | Reiterated | 09/04/26 | ||
| Unknown AnalystNot Ranked | Shenwan Hongyuan | $1.33 | buy | 114.70%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | China Merchants Securities | $1.25 | buy | 102.31%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | $0.98→$1.28 | buy | 106.44%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | CMB International Securities | $1.11 | buy | 79.60%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Citi | $1.28→$1.38 | buy | 122.95%Upside | Reiterated | 08/20/26 | ||
| Alexis Yan | Morgan Stanley | $1.00 | buy | 61.02%Upside | Reiterated | 08/19/26 | ||
| Unknown AnalystNot Ranked | Daiwa | $0.89 | buy | 44.51%Upside | Reiterated | 08/12/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | $0.92 | buy | 48.64%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | Nomura | $1.05 | buy | 70.52%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | HSBC | $1.08 | buy | 75.47%Upside | Reiterated | 07/10/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | $1.15 | buy | 85.79%Upside | Reiterated | 06/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystCICCNot Ranked | BuyReiterated$1.14 | 11/05/26 | 83.73%Upside | ||
| Unknown AnalystBank of ChinaNot Ranked | BuyReiterated$0.97 | 11/05/26 | 56.89%Upside | ||
| Unknown AnalystUBSNot Ranked | BuyReiterated$0.98 | 10/28/26 | 58.96%Upside | ||
| Unknown AnalystGuosheng SecuritiesNot Ranked | BuyReiterated$1.05 | 09/04/26 | 69.28%Upside | ||
| Unknown AnalystShenwan HongyuanNot Ranked | BuyReiterated$1.33 | 08/26/26 | 114.70%Upside | ||
| Unknown AnalystChina Merchants SecuritiesNot Ranked | BuyReiterated$1.25 | 08/25/26 | 102.31%Upside | ||
| Unknown AnalystBOCOM International Holdings CompanyNot Ranked | BuyReiterated$0.98→$1.28 | 08/21/26 | 106.44%Upside | ||
| Unknown AnalystCMB International SecuritiesNot Ranked | BuyReiterated$1.11 | 08/21/26 | 79.60%Upside | ||
| Unknown AnalystCitiNot Ranked | BuyReiterated$1.28→$1.38 | 08/20/26 | 122.95%Upside | ||
| Alexis YanMorgan Stanley | BuyReiterated$1.00 | 08/19/26 | 61.02%Upside | ||
| Unknown AnalystDaiwaNot Ranked | BuyReiterated$0.89 | 08/12/26 | 44.51%Upside | ||
| Unknown AnalystUOB Kay HianNot Ranked | BuyReiterated$0.92 | 07/24/26 | 48.64%Upside | ||
| Unknown AnalystNomuraNot Ranked | BuyReiterated$1.05 | 07/24/26 | 70.52%Upside | ||
| Unknown AnalystHSBCNot Ranked | BuyReiterated$1.08 | 07/10/26 | 75.47%Upside | ||
| Unknown AnalystCitic SecuritiesNot Ranked | BuyReiterated$1.15 | 06/25/26 | 85.79%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Sino Biopharmaceutical
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
+0.15%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.15% per trade.
1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-4.10%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -4.10% per trade.
2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-4.10%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -4.10% per trade.
SBMFF Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 14 | 12 | 7 | 3 |
| Buy | 3 | 4 | 5 | 3 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 18 | 17 | 10 | 4 |
In the current month, SBMFF has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SBMFF average Analyst price target in the past 3 months is 1.12.
SBMFF Financial Forecast
High$0.01
Consensus$0.01
Low$0.01
SBMFF Earnings Forecast
Next quarter’s earnings estimate for SBMFF is $0.01 with a range of $0.01 to $0.01. The previous quarter’s EPS was $0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$2.53B
Consensus$2.5B
Low$2.48B
SBMFF Sales Forecast
Next quarter’s sales forecast for SBMFF is $2.50B with a range of $2.48B to $2.53B. The previous quarter’s sales results were $2.82B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
SBMFF Stock Forecast FAQ
What is SBMFF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sino Biopharmaceutical’s 12-month average price target is $1.12.
What is SBMFF’s upside potential, based on the analysts’ average price target?
Sino Biopharmaceutical has 81.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SBMFF a Buy, Sell or Hold?
Sino Biopharmaceutical has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sino Biopharmaceutical’s price target?
The average price target for Sino Biopharmaceutical is $1.12. This is based on 11 12-month price targets, issued in the past 3 months. The highest analyst price target is $1.38, the lowest forecast is $0.89. The average price target represents a 81.85% increase from the current price of $0.618.
What do analysts say about Sino Biopharmaceutical?
Sino Biopharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of SBMFF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
